Related references
Note: Only part of the references are listed.CysLTR1 promoter polymorphism and requirement for leukotriene receptor antagonist in aspirin-intolerant asthma patients
Seung-Hyun Kim et al.
PHARMACOGENOMICS (2007)
Association between polymorphisms in prostanoid receptor genes and aspirin-intolerant asthma
Sang-Heon Kim et al.
PHARMACOGENETICS AND GENOMICS (2007)
Pharmacogenetics of the 5-lipoxygenase biosynthetic pathway and variable clinical response to montelukast
Michael Klotsman et al.
PHARMACOGENETICS AND GENOMICS (2007)
Association of TNF-α genetic polymorphism with HLA DPB1*0301
S. -H. Kim et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2006)
Cysteinyl leukotriene receptor 1 promoter polymorphism is associated with aspirin-intolerant asthma in males
SH Kim et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2006)
Influence of leukotriene pathway polymorphisms on response to montelukast in asthma
JJ Lima et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Association analysis of cysteinyl-leukotriene receptor 2 (CYSLTR2) polymorphisms with aspirin intolerance in asthmatics
JS Park et al.
PHARMACOGENETICS AND GENOMICS (2005)
Polymorphism of tandem repeat in promoter of 5-lipoxygenase in ASA-intolerant asthma: a positive association with airway hyperresponsiveness
SH Kim et al.
ALLERGY (2005)
Functional promoter polymorphism in the TBX21 gene associated with aspirin-induced asthma
M Akahoshi et al.
HUMAN GENETICS (2005)
Association of thromboxane A2 receptor gene polymorphism with the phenotype of acetyl salicylic acid-intolerant asthma
SH Kim et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2005)
Leukotriene-related gene polymorphisms in ASA-intolerant asthma: an association with a haplotype of 5-lipoxygenase
JH Choi et al.
HUMAN GENETICS (2004)
HLA association in aspirin-intolerant asthma: DPB1*0301 as a strong marker in a Korean population
JH Choi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
The HLA-DPB1*0301 marker might predict the requirement for leukotriene receptor antagonist in patients with aspirin-intolerant asthma
HS Park et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma
W Szczeklik et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Polymorphisms in the prostaglandin E2 receptor subtype 2 gene confer susceptibility to aspirin-intolerant asthma:: a candidate gene approach
N Jinnai et al.
HUMAN MOLECULAR GENETICS (2004)
Adverse respiratory reactions to aspirin and nonsteroidal anti-inflammatory drugs
RA Simon
CURRENT ALLERGY AND ASTHMA REPORTS (2004)
Leukotriene C4 synthase polymorphisms and responsiveness to leukotriene antagonists in asthma
GP Currie et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Aspirin-induced asthma: Advances in pathogenesis, diagnosis, and management
A Szczeklik et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)
Effect of montelukast on time-course of exhaled nitric oxide in asthma: Influence of LTC4 synthase A(-444)C polymorphism
GJ Whelan et al.
PEDIATRIC PULMONOLOGY (2003)
Clinical and genetic features underlying the response of patients with bronchial asthma to treatment with a leukotriene receptor antagonist
L Mastalerz et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2002)
The effect of leukotriene-modifier drugs on aspirin-induced asthma and rhinitis reactions
MP Berges-Gimeno et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2002)
Leukotriene C4 synthase gene A(-444)C polymorphism and clinical response to a CYS-LT1 antagonist, pranlukast, in Japanese patients with moderate asthma
K Asano et al.
PHARMACOGENETICS (2002)
Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma
A Antczak et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Leukotriene C4 synthase promoter polymorphism in Japanese patients with aspirin-induced asthma
Y Kawagishi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2002)
5-lipoxygenase polymorphism and in-vivo response to leukotriene receptor antagonists
SJ Fowler et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients
Y Obase et al.
CHEST (2002)
Release of cysteinyl leukotrienes with aspirin stimulation and the effect of prostaglandin E2 on this release from peripheral blood leucocytes in aspirin-induced asthmatic patients
G Çelik et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2001)
Variant LTC4 synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast
AP Sampson et al.
THORAX (2000)
5′ Flanking region polymorphism of the gene encoding leukotriene C4 synthase does not correlate with the aspirin-intolerant asthma phenotype in the United States
R Van Sambeek et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2000)